| Literature DB >> 30275051 |
Arthur P Arnold1, Christine M Disteche2.
Abstract
Investigating sex differences in cancer will improve therapy for both sexes and discover sex-specific protective mechanisms. Two recent analyses by Lopes-Ramos and colleagues and Li and colleagues point to specific gene regulatory networks and genomic alterations associated with sex differences in tumor incidence and progression. Integrating this information with emerging concepts about sex biases in the genome may help focus attention on factors that shift the odds for tumor growth. Cancer Res; 78(19); 5504-5. ©2018 AACR See related articles by Li et al., p. 5527, and Lopes-Ramos et al., p. 5538. ©2018 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30275051 PMCID: PMC6204258 DOI: 10.1158/0008-5472.CAN-18-2219
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701